Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

한국어

HASS Corp.

하스450330KOSDAQSector: Pharma & Biotech
₩5,0700.59%Market cap ₩41.5BAs of Sep 1, 2026 close · updated once daily
Market cap
₩41.5B
#1237 in KOSDAQ
26.8x
Sector median 16.3x (profitable cos.)
0.89x
Sector median 1.61x
1.0%
Sector median 0.0%
B
Grade B62.8 ptsTop 27% of 2,523 graded stocksMethodology v2.0

As of Sep 1, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SABCurrentCDF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band B with a total score of 62.8 points.

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

1-year closing price

Loading closing price history…
 
Low ₩3,790High ₩7,800
Latest close
Price change by period
1W
0.70%
1M
28.50%
3M
7.90%
1Y
25.70%

As of the Sep 1, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

72.3/100
How much debt does it carry relative to equity?
18.3%
Sector median 51.6%
Sector lowhighTop 20.4% in sector
Can it cover what's due within a year?
406.8%
Sector median 191.7%
Sector lowhighTop 30.2% in sector
How much of revenue becomes profit?
5.4%
Sector median -2.4%
Sector lowhighTop 27.7% in sector
How much did it earn on its own capital?
3.3%
Sector median -4.5%
Sector lowhighTop 32.6% in sector

Source filing: annual report (consolidated) — view original

2

Growth momentum

32.7/100
How much did revenue grow in a year?
2.6%
Sector median 6.4%
Sector lowhighBottom 40.2% in sector
Did core profits grow in a year?
-27.1%
Sector median 3.6%
Sector lowhighBottom 25.1% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original

3

Price attractiveness

70.3/100
Is the price expensive relative to earnings?
26.8x
Sector median P/E of profitable peers 16.3x · 58% loss-making
Sector lowhighTop 27.7% in sector
Is the price expensive relative to book value?
0.89x
Sector median 1.61x
Sector lowhighTop 31.8% in sector

Valuation uses the Sep 1, 2026 close and market cap

4

Shareholder Return

Single-indicator axis83.8/100
Does the company actually pay dividends?
1.0%
Sector median 0.0%
Sector lowhighTop 16.2% in sector

Dividend per share (annual)

Cash dividend per common share as stated in annual reports. ₩0 means no dividend that year.

Dividends & treasury shares

Total cash dividends (FY2025)
₩491M
Cash payout ratio, consolidated (FY2025)
31.7%

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (consolidated) — view original

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 5 met · 2 not met · 2 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Met
₩1.5B
Positive operating cash flow
Whether cash flow from operations is above zero.
Met
₩1.8B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Not computable

Not computed — required financial data is unavailable

Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Met
₩1.8B vs ₩1.5B
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Met
17.2% → 15.4%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Met
333.6% → 406.8%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Not met
7,836,009 → 8,186,843
Operating margin up
Whether operating income over revenue rose from the prior year.
Not met
7.7% → 5.4%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Not computable

Not computed — required financial data is unavailable

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original

Grade change history

Jul 23, 2026B

Methodology version change (v2.0 applied)

Jul 15, 2026BVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 13, 2026Source
Periodic report filedMay 14, 2026Source

View in the filings calendar →